Inorganic Chemistry
Article
NMe4[FeIIMST],6b and H3TST7 were prepared according to literature
procedures.
(s), 816 (s), 666 (s), 553 (s). λmax, nm (DCM, ε, M−1 cm−1): 355
(5500). EPR (1:1 DCM:THF, 77 K): g = 9.7, 4.3.
Complex Syntheses and Reactivity Studies. NMe4[FeIIMST-
(OH2)]. A suspension of NMe4[FeIIMST] (0.100 g, 0.12 mmol) in 4
mL of THF at room temperature was treated with 3 μL (0.17 mmol)
of H2O via syringe, causing the solution to become homogeneous. The
reaction was stirred vigorously for 5 min, after which the solvent was
removed under vacuum. The resulting residue was redissolved in
dichloromethane (DCM) and filtered through Celite to remove fine
particulate solid. The product was crystallized from the DCM filtrate
via diffusion of pentane to give 95 mg (93%) of NMe4[FeIIMST-
(OH2)] as colorless needle crystals. Anal. Calcd for NMe4[FeIIMST-
(OH2)], C37H59N5O7S3Fe: C, 53.03; H, 7.10; N, 8.36. Found: C,
53.00; H, 7.03; N, 8.38. FTIR (KBr disc, cm−1, selected bands, strong
(s), medium (m), weak (w)): 3255 (m), 2968 (m), 2852 (m), 1604
(w), 1491 (m), 1255 (s), 1127 (s), 974 (s), 812 (s), 654 (s).
NMe4[FeIII−O−MST]. A solution of NMe4[FeIIMST] (0.250 g, 0.30
mmol) in 15 mL of DCM at room temperature was treated with a
solution of NMO (72 mg, 6.1 mmol) in 5 mL of DCM, resulting in an
immediate color change to red. The reaction was stirred for 3 h and
then filtered through Celite. The product was recrystallized twice from
DCM via pentane diffusion to give 128 mg (50%) of orange crystals.
Anal. Calcd for NMe 4 [FeI I I −O−MST]·0. 5CH2 Cl2 ,
C37.5H57N5O7S3Cl2Fe: C, 51.34; H, 6.55; N, 7.98. Found: C, 51.69;
H, 6.51; N, 7.77. FTIR (KBr disc, cm−1, selected bands, strong (s),
medium (m), weak (w)): 3029 (w), 2932 (m), 2855 (m), 1604 (m),
1488 (m), 1292 (s), 1136 (s), 958 (s), 797 (s), 654 (s). λmax, nm
(DCM, ε, M−1 cm−1): 351 (7500). EPR (1:1 DCM:THF, 77 K): g =
9.0, 4.2.
Ligand Isolation Studies. In a typical experiment, a DCM
solution of the reaction mixture was brought out of the dry box and
extracted with 1 M HCl. The organic layer was washed with brine,
dried over MgSO4, and filtered. The DCM solution was then passed
through a plug of silica, which was flushed with additional DCM. The
ligand was eluted from the silica with 5% MeOH in DCM and the
solvent removed under vacuum. The products were analyzed by
electrospray ionization mass spectrometry (ESI-MS) and NMR
spectroscopy.
Electronic Absorption Studies. In a typical experiment, a 0.2
mM stock solution of the metal complex was prepared in the glove
box, and 3 mL of the solution was transferred to a quartz cuvette,
which was sealed with a rubber septum. The cuvette was brought out
of the glove box and allowed to equilibrate in the sample holder at 25
°C for 10 min before NMO was added as a 30 mM solution via
syringe.
Substrate Oxidation Studies. In a typical experiment, a solution
of NMO was added in one portion to a solution containing the FeII
complex and DHA. After 3 h, the solvent was evaporated to dryness
and the resulting yellow residue stirred in Et2O. Et2O was then filtered
through Celite, passed through a silica plug, and evaporated to give the
DHA products as an off-white residue. The residue was redissolved in
CDCl3, and the ratio of products was determined by integration of
1
their signals in the H NMR spectrum. The Fe-containing products
were redissolved in DCM and recrystallized by Et2O layering.
Physical Methods. Electronic absorption spectra were recorded in
a 1.0 or 0.1 cm quartz cuvette on a Cary 50 spectrophotometer or an
8453 Agilent UV−vis spectrometer equipped with an Unisoku
Unispeks cryostat. Negative mode electrospray ionization mass spectra
were collected using a Micromass MS Technologies LCT Premier
Mass Spectrometer. X-band (9.28 GHz) EPR spectra were collected as
frozen solutions using a Bruker EMX spectrometer equipped with an
ER041XG microwave bridge. IR spectra were recorded on a Varian
800 Scimitar Series FTIR spectrometer as KBr disks or as a solution
using a Beckman liquid IR cell.
X-ray Crystallographic Methods. A Bruker SMART APEX II
diffractometer was used to collect all data. The APEX28 program
package was used to determine the unit-cell parameters and for data
collections. The raw frame data was processed using SAINT9 and
SADABS10 to yield the reflection data file. Subsequent calculations
were carried out using the SHELXTL11 program. Structures were
solved by direct methods and refined on F2 by full-matrix least-squares
techniques. Analytical scattering factors12 for neutral atoms were used
throughout the analysis. Hydrogen atoms were included using a riding
model. Hydrogen atoms H(1) of NMe4[FeIIITST(OH)] and H(1)
and H(2) NMe4[FeIIMST(OH2)] were located from a difference-
Fourier map and refined (x, y, z, and Uiso). Data sets of both
NMe4[FeIIITST(OH)] and NMe4[FeIII−O−MST] contained several
high residuals in the final difference-Fourier map. It was not possible to
determine the nature of the residuals, although it is probable that a
pentane or DCM solvent molecule was present. The SQUEEZE
routine in the PLATON13 program package was used to account for
the electrons in the solvent-accessible voids. In the NMe4[FeIIMST-
(OH2)] structure, the (NMe4)+ counterion was disordered. Carbon
atoms C(35)−C(40) were included using multiple components with
partial site-occupancy factors.
15-crown-5⊃Ca−(μ-OH)−FeIIIMST]OTf.
A solution of
NMe4[FeIIMST] (50 mg, 0.061 mmol) and Ca⊃15-crown-5(OTf)2
(37 mg, 0.067 mmol) in 3 mL of DCM at room temperature was
treated with a solution of NMO (14 mg, 0.12 mmol) in 2 mL of DCM,
resulting in an immediate color change to orange. After 5 h, the
reaction mixture was filtered through Celite and the product was
recrystallized twice via pentane diffusion to give 60 mg (85%) of
yellow-orange crystals. Anal. Calcd for [15-crown-5⊃CaII−(μ-OH)−
FeIIIMST]OTf·0.5CH2Cl2, C44.5H67CaClF3N4O15S4Fe: C, 44.00; H,
5.56; N, 4.61. Found: C, 44.13; H, 5.31; N, 4.50. FTIR (KBr disc,
cm−1, selected bands, strong (s), medium (m), weak (w)): 3379 (m),
2937 (m), 2868 (m), 1604 (w), 1266 (s), 1144 (s), 1090 (s), 1031 (s),
955 (s), 811 (s), 659 (s), 638 (s). λmax, nm (DCM, ε, M−1 cm−1): 383
(6000). EPR (1:1 DCM:THF, 77 K): g = 9.4, 4.7, 4.2
NMe4[FeIITST(OH2)]. A solution of H3TST (0.200 g, 0.33 mmol) in
4 mL of anhydrous dimethylacetimide (DMA) at room temperature
was treated with 3 equiv of solid NaH (24 mg, 1.0 mmol), causing H2
evolution and precipitation of the deprotonated ligand. After the
evolution of H2 gas ceased, Fe(OAc)2 (57 mg, 0.33 mmol) and
NMe4OAc (44 mg, 0.33 mmol) were added to the heterogeneous
mixture, which was then stirred for 3 h. One equivalent (6 μL) of H2O
was then added via syringe and the reaction mixture filtered through a
medium-porosity frit to remove 3 equiv of insoluble NaOAc (79 mg,
0.96 mmol). Vapor diffusion of Et2O into the pale yellow filtrate gave
the product as pale blue crystals in 90% yield. Anal. Calcd for
NMe4[FeIITST(OH2)], C31H47N5O7S3Fe: C, 49.40; H, 6.28; N, 9.29.
Found: C, 49.13; H, 6.23; N, 9.14. FTIR (KBr disc, cm−1, selected
bands, strong (s), medium (m), weak (w)): 3257 (m), 3037 (w), 2896
(w), 2845 (m), 1599 (w), 1494 (m), 1246 (s), 1129 (s), 973 (s), 815
(s), 663 (s), 597 (m), 555 (s).
NMe4[FeIIITST(OH)]. A solution of NMe4[FeIITST(H2O)] (0.100 g,
0.13 mmol) in 6 mL of DCM at room temperature was treated with a
solution of NMO (15 mg, 0.13 mmol) in 2 mL of DCM, causing an
immediate color change to red. The reaction was stirred for 4 h, during
which time the color faded to orange. After filtering through Celite, the
product was recrystallized twice by layering the DCM solution under
Et2O to give 60 mg (60%) of yellow-orange crystals. Analy. Calcd for
NMe4[FeIIITST(OH)], C31H46N5O7S3Fe: C, 49.46; H, 6.16; N, 9.30.
Found: C, 49.55; H, 6.00; N, 8.98. FTIR (KBr disc, cm−1, selected
bands, strong (s), medium (m), weak (w)): 3450 (m), 3036 (w), 2962
(w), 2859 (m), 1599 (w), 1490 (m), 1270 (s), 1138 (s), 1091 (s), 962
RESULTS AND DISCUSSION
■
Reactivity of the [FeIIMST]− Complex with Dioxygen.
We previously reported the preparation of bimetallic complexes
that are supported by [MST]3−.6,14 We discovered that treating
NMe4[FeIIMST] or NMe4[MnIIMST] with dioxygen in the
presence of a second metal ion resulted in formation of
Fe(III)− or Mn(III)−hydroxide complexes with the second
metal ion coordinated through the hydroxide ligand and two of
the sulfonamido ligand arms of [MST]3− (Scheme 1).6 In the
B
dx.doi.org/10.1021/ic501531g | Inorg. Chem. XXXX, XXX, XXX−XXX